K2M acquired the Palo Alto Cervical Static Corpectomy Cage System from Cardinal Spine.
Here are four things to know:
1. Palo Alto was the first static corpectomy cage to receive FDA clearance for the cervical spine, and K2M acquired all associated intellectual property and product inventory from Cardinal Spine.
2. The system is indicated for use in the cervical spine to replace diseased or damaged vertebral bodies, or during reconstruction to achieve spinal cord and neural tissue decompression. Surgeons can use the system with allograft or allogenic bone graft as an adjunct to fusion.
3. Long-term clinical data shows Palo Alto can achieve a 96 percent fusion rate. "The trapezoidal design helps increase the graft-host surface contact area while providing resistance to posterior cage migration," said Frank Castro Jr., MD, an orthopedic surgeon at Baptist Health Floyd in New Albany, Ind., and founder of Cardinal Spine.
4. K2M plans to feature the new technology at the North American Spine Society annual meeting. "We look forward to fully integrating this clinically supported technology into our differentiated product portfolio, which when complemented by our comprehensive Balance ACS platform, allows surgeons to address the full range of spinal pathologies, and ultimately, to facilitate Total Body Balance in their patients," said K2M Chairman, President and CEO Eric Major.